samantha budd haeberlein, vp, clinical development, discusses alzheimer’s disease
Published 6 years ago • 644 plays • Length 0:56Download video MP4
Download video MP3
Similar videos
-
1:05
samantha budd haeberlein, vp, clinical development, discusses alzheimer’s disease
-
2:16
samantha budd haeberlien, phd: progress in alzheimer drug development
-
5:11
reflections on today’s milestone in alzheimer’s disease
-
1:06
samantha budd haeberlein, phd: the tango ii trial of biib092
-
1:11:57
doctor explains how alzheimer's reversal is real-with dr.bredesen | the empowering neurologist ep130
-
13:57
what you can do to prevent alzheimer's | lisa genova | ted
-
3:01
potential breakthrough: new treatment for alzheimer's
-
6:03
mechanism of alzheimer's disease
-
0:19
clinical trials: revolutionizing the treatments for alzheimer's
-
2:28
dominic walsh | decoding the pathology of alzheimer’s
-
16:02
what’s the controversy behind biogen’s alzheimer’s drug?
-
4:06
the alzheimer’s puzzle: unlocking the science
-
3:35
reflections on today’s milestone in alzheimer’s disease
-
3:27
alzheimer’s reversal
-
0:57
what you need to know about biogen’s new alzheimer’s treatment
-
4:32
biogen: focused on furthering alzheimer’s disease research & treatment: hope in the age of dementia
-
3:31
that pricey new alzheimer's drug? still not great
-
20:52
clinical trial participant 'biogen's aducanumab was working' | patient perspectives | being patient
-
0:48
biogen alzheimer's drug closer to approval
-
0:33
first new drug for alzheimer's in 20 years approved by fda